全文获取类型
收费全文 | 47542篇 |
免费 | 5320篇 |
国内免费 | 3059篇 |
专业分类
电工技术 | 4392篇 |
技术理论 | 2篇 |
综合类 | 4133篇 |
化学工业 | 6261篇 |
金属工艺 | 3155篇 |
机械仪表 | 3187篇 |
建筑科学 | 3711篇 |
矿业工程 | 2005篇 |
能源动力 | 1531篇 |
轻工业 | 3586篇 |
水利工程 | 1430篇 |
石油天然气 | 2276篇 |
武器工业 | 755篇 |
无线电 | 5203篇 |
一般工业技术 | 4647篇 |
冶金工业 | 2639篇 |
原子能技术 | 761篇 |
自动化技术 | 6247篇 |
出版年
2024年 | 271篇 |
2023年 | 756篇 |
2022年 | 1680篇 |
2021年 | 2418篇 |
2020年 | 1686篇 |
2019年 | 1260篇 |
2018年 | 1453篇 |
2017年 | 1763篇 |
2016年 | 1472篇 |
2015年 | 2240篇 |
2014年 | 2789篇 |
2013年 | 3201篇 |
2012年 | 3840篇 |
2011年 | 3918篇 |
2010年 | 3565篇 |
2009年 | 3480篇 |
2008年 | 3422篇 |
2007年 | 3252篇 |
2006年 | 2896篇 |
2005年 | 2317篇 |
2004年 | 1622篇 |
2003年 | 1114篇 |
2002年 | 1052篇 |
2001年 | 873篇 |
2000年 | 750篇 |
1999年 | 564篇 |
1998年 | 549篇 |
1997年 | 396篇 |
1996年 | 296篇 |
1995年 | 210篇 |
1994年 | 170篇 |
1993年 | 152篇 |
1992年 | 77篇 |
1991年 | 71篇 |
1990年 | 49篇 |
1989年 | 39篇 |
1988年 | 32篇 |
1987年 | 20篇 |
1986年 | 17篇 |
1985年 | 13篇 |
1983年 | 4篇 |
1982年 | 11篇 |
1981年 | 23篇 |
1980年 | 18篇 |
1979年 | 6篇 |
1978年 | 4篇 |
1977年 | 27篇 |
1976年 | 60篇 |
1959年 | 10篇 |
1951年 | 6篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
31.
LaNiO3导电金属氧化物薄膜在现代应用科学研究中作为电极和过渡阻挡层倍受青睐,它具有很好的导电特性和稳定性。该文采用射频溅射法制备了具有(100)择优取向的赝立方结构LaNiO3-x薄膜,并进行了原位热处理。实验结果表明,在265℃的处理条件下,LaNiO3薄膜表现出不稳定性,晶格中的氧在2h内失去了2.7%。氧的损失对品格结构没有明显影响,但薄膜的导电性能明显下降,折射率和消光系数也具有相同幅度的下降。对薄膜的应用具有一定的影响。该文从LaNiO3薄膜的导电机理方面对实验现象给出了分析和解释。 相似文献
32.
33.
Composite element model for discontinuous rock masses 总被引:2,自引:0,他引:2
34.
B-ISDN是现代电信网的发展方向,拥塞控制技术则是其中的一个重要问题。由于B-ISDN采用新的信息传递方式──ATM,使传统的拥塞控制方法不再适用。本文依据ITU-T有关建议的最新内容对B-ISDN拥塞控制的基本思想、工作机制以及其中的主要功能作了较为详细的分析讨论,并提出了一些B-ISDN拥塞控制技术中尚需进一步研究的问题。 相似文献
35.
36.
37.
EJ Shpall SM Stemmer L Hami WA Franklin L Shaw HS Bonner SI Bearman WP Peters RC Bast W McCulloch 《Canadian Metallurgical Quarterly》1994,83(11):3132-3137
4-Hydroperoxycyclophosphamide (4-HC), a commonly used marrow-purging agent, is active against many tumors, but is also toxic to normal marrow progenitors. Amifostine (WR-2721) is a sulfhydryl compound with chemoprotectant activity. Preclinical studies using suspensions of bone marrow and breast cancer cells demonstrated that ex vivo treatment with amifostine followed by 4-HC resulted in protection of marrow progenitors, with no compromise in the antitumor effect of 4-HC. This fact stimulated the development of a clinical trial. Bone marrow was harvested from 15 poor-prognosis breast cancer patients and randomly assigned to ex vivo treatment with amifostine followed by 4-HC (amifostine + 4-HC), or treatment with 4-HC alone. High-dose chemotherapy was then administered followed by infusion of the purged autologous bone marrow support (ABMS). Leukocyte engraftment, defined as a white blood cell count > or = 1 x 10(9)/L, was achieved in an average of 26 days for patients whose marrow was purged with amifostine + 4-HC versus 36 days for patients whose marrow was purged with 4-HC alone (P = .032). The average number of platelet transfusions (12 v 29; P = .017) and days of antibiotic therapy (28 v 40; P = .012) were significantly less for patients whose marrow was exposed to amifostine + 4-HC, compared with 4-HC alone. Unpurged backup marrow fractions were infused into three patients whose marrow was purged with 4-HC alone, because of inadequate marrow recovery. None of the patients who received amifostine + 4-HC-purged marrow required a backup marrow fraction. Complete remissions were achieved in 83% of patients with measurable disease, with no difference between the two cohorts. Forty-three percent of patients remained alive and progression-free at a mean of 13 months posttransplant. There was no significant difference in the rate or pattern of relapse for patients whose marrow was purged with amifostine + 4-HC compared with those whose marrow was purged with 4-HC alone. Ex vivo treatment of marrow with amifostine significantly shortens the time to marrow recovery, thereby reducing the risk of myelosuppressive complications in breast cancer patients receiving high-dose chemotherapy and 4-HC-purged ABMS. Since supportive care requirements are also significantly decreased, amifostine may reduce the cost of such therapy. 相似文献
38.
A case is presented of a 3 1/2-year-old girl with a clinical picture of very severe psychomotor retardation, autistic behavior, and repetitive convulsive episodes starting in the neonatal period and resistant to any pharmacological treatment. Electroencephalography showed generalized abnormalities. Magnetic resonance imaging of the brain disclosed arachnoid cysts in both temporal fossae with marked hypoplasia of both temporal lobes. It is proposed that the severity of symptoms is related to the magnitude of underlying anatomical lesions as well as the associated intractable epilepsy. 相似文献
39.
40.
Quantum-mechanical reaction rate constants were calculated from centroid molecular dynamics (CMD) simulations, for the case of barrier crossing in an asymmetrical double-well potential bilinearly coupled to a harmonic bath. The calculation is based on a recently proposed formulation of the reaction rate constant in terms of the position—flux correlation function, which can be approximated via CMD in a well-defined manner. The predictions of CMD and various simplified versions of it are compared to exact results, which were obtained via the quasi-adiabatic propagator path integral (QUAPI) method, and/or path integral quantum transition state theory (PI-QTST). The predictions based on CMD are found to be in good agreement with both. 相似文献